Cite

HARVARD Citation

    Gu, Z. et al. (2021). The angiotensin-converting enzyme inhibitor, captopril, suppressed hepatic stellate cell activation via NF-kappaB or wnt3α/β-catenin pathway. Bioengineered. 12 (1), pp. 8370-8377. [Online]. 
  
Back to record